Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$58.06 USD
+2.61 (4.71%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $58.36 +0.30 (0.52%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.25 | -1.60% |
Earnings Summary
For their last quarter, Corbus Pharmaceuticals (CRBP) reported earnings of -$0.83 per share, beating the Zacks Consensus Estimate of $-1.09 per share. This reflects a positive earnings surprise of 23.85%. Look out for CRBP's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.25 per share, reflecting a year-over-year increase of 39.02%.
Earnings History
Price & Consensus
Zacks News for CRBP
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
CRBP: What are Zacks experts saying now?
Zacks Private Portfolio Services